Clene, Inc. (CLNN)
4.435
+0.12
(+2.66%)
USD |
NASDAQ |
Aug 24, 16:00
4.435
0.00 (0.00%)
After-Hours: 20:00
Clene 1 Year Total Returns (Daily) : -21.64% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -21.64% |
| August 21, 2026 | -19.10% |
| August 20, 2026 | -22.24% |
| August 19, 2026 | -6.47% |
| August 18, 2026 | -3.54% |
| August 17, 2026 | 16.02% |
| August 14, 2026 | 15.00% |
| August 13, 2026 | 14.79% |
| August 12, 2026 | 10.00% |
| August 11, 2026 | 14.40% |
| August 10, 2026 | 40.22% |
| August 07, 2026 | 43.87% |
| August 06, 2026 | 45.90% |
| August 05, 2026 | 45.80% |
| August 04, 2026 | 41.18% |
| August 03, 2026 | 48.71% |
| July 31, 2026 | 41.67% |
| July 30, 2026 | 44.41% |
| July 29, 2026 | 40.48% |
| July 28, 2026 | 46.76% |
| July 27, 2026 | 49.59% |
| July 24, 2026 | 47.27% |
| July 23, 2026 | 46.52% |
| July 22, 2026 | 52.76% |
| July 21, 2026 | 51.16% |
| Date | Value |
|---|---|
| July 20, 2026 | 50.00% |
| July 17, 2026 | 51.79% |
| July 16, 2026 | 50.93% |
| July 15, 2026 | 62.70% |
| July 14, 2026 | 65.95% |
| July 13, 2026 | 77.99% |
| July 10, 2026 | 66.76% |
| July 09, 2026 | 63.19% |
| July 08, 2026 | 60.00% |
| July 07, 2026 | 58.14% |
| July 06, 2026 | 54.10% |
| July 02, 2026 | 54.43% |
| July 01, 2026 | 57.18% |
| June 30, 2026 | 57.42% |
| June 29, 2026 | 68.48% |
| June 26, 2026 | 54.59% |
| June 25, 2026 | 41.22% |
| June 24, 2026 | 39.32% |
| June 23, 2026 | 40.73% |
| June 22, 2026 | 37.62% |
| June 18, 2026 | 37.53% |
| June 17, 2026 | 40.19% |
| June 16, 2026 | 32.35% |
| June 15, 2026 | 40.73% |
| June 12, 2026 | 43.14% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| NovelStem International Corp. | -47.22% |
| Brainstorm Cell Therapeutics, Inc. | 54.99% |
| Summit Therapeutics, Inc. | -51.41% |
| Kezar Life Sciences, Inc. | 79.56% |
| Protara Therapeutics, Inc. | 24.44% |